| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a leading pharmaceutical ..
>Volltext.. |
| 877569 Mio. EUR |
| 905440.15 Mio. EUR |
| 51024.49 Mio. EUR |
| 24290.21 Mio. EUR |
| 15810.69 Mio. EUR |
| 17.39 EUR |
| 36500.92 Mio. EUR |
| 8408.42 Mio. EUR |
| 13792.8 Mio. EUR |
| 0.25 |
| 37.97% |
| 108.73% |
| 5.15 EUR |
| 0.56% |
| 0.64% |
| 14.11.25 - 1.2880499€ 15.08.25 - 1.287€ >weitere anzeigen... |
| 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 330.900.755 USD. |
| ELI LILLY, LILLY DEUTSCHLAND |
| 15.01.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|